Filter posts

The Art of the Biotech Deal at BIO CEO & Investor Conference

Professionals from all areas of biotechnology convened for the 20th annual BIO CEO & Investor …

#BIOCEO18: Tackling the Opioid Crisis

Opioid addiction is plaguing communities across the country, leaving in its wake countless victims, devastated …

#BIOCEO18: A Bright Future

“A transformative year in medicine.” That’s how BIO President and CEO Jim Greenwood recently described …

#BIOCEO18: Paradigm Shift Creating New Opportunities in China

The past few years have been a time of tremendous change in the world’s second …

#BIOCEO18: “A Moment Decades in the Making”

It’s a first-of-its-kind gene therapy ever approved by the U.S. Food and Drug Administration, marking …

BIO Releases Report on Investment in Pain and Addiction Therapeutics

BIO’s Industry Analysis team has released its second report in a new series on the …

New Report Series Launched on The State of Innovation in Highly Prevalent Chronic Diseases

BIO’s Industry Analysis team has released its first report in a new series on the …

BIO CEO and Investor Conference at the Center of Biotech Innovation

The 20th annual BIO CEO & Investor Conference will be held on February 12-13, 2018 …

BIO CEO: The Perfect Place to Continue The Momentum From A Strong 2017 Biotech Market

The 20th Annual BIO CEO & Investor Conference, taking place February 12-13 in New York …

Biotech Investment and Deal-making are Front and Center at #BIOCEO18

The business of making life-saving treatments is fraught with setbacks, challenges and failures. Along the …